300143 盈康生命
已收盘 08-23 15:00:00
资讯
新帖
简况
盈康生命(300143.SZ)发布上半年业绩,净利润5480.11万元,同比下降22.44%
智通财经 · 08-22 19:58
盈康生命(300143.SZ)发布上半年业绩,净利润5480.11万元,同比下降22.44%
盈康生命上半年营收同比增长逾13.7% 肿瘤业务规模持续增长
证券之星 · 08-22 18:35
盈康生命上半年营收同比增长逾13.7% 肿瘤业务规模持续增长
盈康生命:截至2024年8月9日,公司股东总数为16,114户
证券之星 · 08-13
盈康生命:截至2024年8月9日,公司股东总数为16,114户
高压氧舱概念盘中拉升,盈康生命涨2.13%
自选股智能写手 · 08-06
高压氧舱概念盘中拉升,盈康生命涨2.13%
7月29日盈康生命发布公告,其股东增持563.34万股
证券之星 · 07-29
7月29日盈康生命发布公告,其股东增持563.34万股
盈康生命(300143.SZ)控股股东盈康医投增持期过半 累计增持563.34万股
智通财经 · 07-29
盈康生命(300143.SZ)控股股东盈康医投增持期过半 累计增持563.34万股
【盈康生命(300143.SZ)控股股东盈康医投增持期过半 累计增持563.34万股】智通财经APP讯,盈康生命(300143.
智通财经 · 07-29
【盈康生命(300143.SZ)控股股东盈康医投增持期过半 累计增持563.34万股】智通财经APP讯,盈康生命(300143.
盈康生命(300143)7月24日主力资金净卖出448.02万元
证券之星 · 07-25
盈康生命(300143)7月24日主力资金净卖出448.02万元
盈康生命:目前,公司自有医院中四川友谊医院和苏州广慈肿瘤医院已实施DRG支付政策
证券之星 · 07-23
盈康生命:目前,公司自有医院中四川友谊医院和苏州广慈肿瘤医院已实施DRG支付政策
盈康生命荣获证券之星ESG新标杆奖
证券之星 · 07-23
盈康生命荣获证券之星ESG新标杆奖
盈康生命:截至2024年7月19日,公司股东总数为16,124户
证券之星 · 07-22
盈康生命:截至2024年7月19日,公司股东总数为16,124户
盈康生命(300143)7月16日主力资金净卖出3.07万元
证券之星 · 07-17
盈康生命(300143)7月16日主力资金净卖出3.07万元
盈康生命(300143)7月10日股东户数1.65万户,较上期减少0.62%
证券之星 · 07-12
盈康生命(300143)7月10日股东户数1.65万户,较上期减少0.62%
盈康生命(300143)7月9日主力资金净买入68.88万元
证券之星 · 07-10
盈康生命(300143)7月9日主力资金净买入68.88万元
盈康生命旗下医院获“第四届创新医疗案例大赛”二等奖
新浪证券 · 07-09
盈康生命旗下医院获“第四届创新医疗案例大赛”二等奖
盈康生命:7月3日接受机构调研,华宝基金、国盛证券等多家机构参与
证券之星 · 07-03
盈康生命:7月3日接受机构调研,华宝基金、国盛证券等多家机构参与
中邮证券:给予盈康生命买入评级
证券之星 · 07-01
中邮证券:给予盈康生命买入评级
盈康生命涨5.98%,华安证券二个月前给出“买入”评级
证券之星 · 07-01
盈康生命涨5.98%,华安证券二个月前给出“买入”评级
盈康生命9.7亿元定增获审核通过 彰显发展信心
证券 · 06-30
盈康生命9.7亿元定增获审核通过 彰显发展信心
盈康生命定增获深交所审核通过
北京商报 · 06-30
盈康生命定增获深交所审核通过
加载更多
公司概况
公司名称:
盈康生命科技股份有限公司
所属行业:
卫生
上市日期:
2010-12-09
主营业务:
盈康生命科技股份有限公司主营业务为以肿瘤为特色的医疗服务以及关键场景、关键设备医疗器械的研发、创新和服务。公司主要产品和服务有伽玛刀及医疗服务。公司在医疗器械方面:国内头部伽玛刀领域龙头企业,并率先实现大型放疗设备自主出口,成功打破国际大型公司全球垄断地位。
发行价格:
36.00
{"stockData":{"symbol":"300143","market":"SZ","secType":"STK","nameCN":"盈康生命","latestPrice":7.14,"timestamp":1724396607000,"preClose":7.07,"halted":0,"volume":3056316,"delay":0,"floatShares":642000000,"shares":642000000,"eps":0.1318,"marketStatus":"已收盘","marketStatusCode":5,"change":0.07,"latestTime":"08-23 15:00:00","open":6.99,"high":7.18,"low":6.99,"amount":21621400,"amplitude":0.0269,"askPrice":7.14,"askSize":83,"bidPrice":7.13,"bidSize":33,"shortable":0,"etf":0,"ttmEps":0.1318,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724635800000},"adr":0,"adjPreClose":7.07,"symbolType":"stock","openAndCloseTimeList":[[1724376600000,1724383800000],[1724389200000,1724396400000]],"highLimit":7.78,"lowLimit":6.36,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":642167010,"pbRate":3.32,"roa":"--","roe":"3.95%","epsLYR":0.16,"committee":-0.351679,"marketValue":4585000000,"floatMarketCap":4585000000,"peRate":54.172991,"changeRate":0.0099,"turnoverRate":0.0048,"status":0},"requestUrl":"/m/hq/s/300143","defaultTab":"news","newsList":[{"id":"2461315937","title":"盈康生命(300143.SZ)发布上半年业绩,净利润5480.11万元,同比下降22.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461315937","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461315937?lang=zh_cn&edition=full","pubTime":"2024-08-22 19:58","pubTimestamp":1724327917,"startTime":"0","endTime":"0","summary":"智通财经APP讯,盈康生命(300143.SZ)发布2024年半年度报告,营业收入8.23亿元,同比增长13.74%;归属于上市公司股东的净利润5480.11万元,同比下降22.44%;归属于上市公司股东的扣除非经常性损益的净利润5082.26万元,同比下降24.34%;基本每股收益0.0860元/股。公司聚焦打造预/诊/治/康全产业链生态平台,提供以肿瘤为特色的医疗服务以及关键场景、关键设备的研发、创新和服务。医疗服务板块提供以肿瘤全病程、全周期综合治疗为特色的医疗服务,报告期内肿瘤收入占医疗服务收入比例为28.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1168755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300143"],"gpt_icon":0},{"id":"2461392333","title":"盈康生命上半年营收同比增长逾13.7% 肿瘤业务规模持续增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2461392333","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461392333?lang=zh_cn&edition=full","pubTime":"2024-08-22 18:35","pubTimestamp":1724322922,"startTime":"0","endTime":"0","summary":"今年上半年,盈康生命实现实现营业收入8.23亿元,同比增长13.7%,其中医疗服务营收6.08亿元,同比提升10.7%,医疗器械营收2.15亿元,同比提升23.5%。剔除股权激励费用摊销等一次性事项,盈康生命上半年净利润同比实际为正增长。资料显示,盈康生命是国内领先的肿瘤关键设备综合服务商和肿瘤医疗服务运营商。盈康生命大股东对上市公司的支持也为公司发展注入动能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024082200033894.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143"],"gpt_icon":0},{"id":"2459929285","title":"盈康生命:截至2024年8月9日,公司股东总数为16,114户","url":"https://stock-news.laohu8.com/highlight/detail?id=2459929285","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459929285?lang=zh_cn&edition=full","pubTime":"2024-08-13 17:04","pubTimestamp":1723539880,"startTime":"0","endTime":"0","summary":"证券之星消息,盈康生命(300143)08月13日在投资者关系平台上答复投资者关心的问题。投资者:请问截止8月9日盘后公司登记在册的股东人数是多少?谢谢盈康生命董秘:尊敬的投资者,您好!截至2024年8月9日,公司股东总数为16,114户。感谢您的关注!以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081300033752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2457058311","title":"高压氧舱概念盘中拉升,盈康生命涨2.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457058311","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457058311?lang=zh_cn&edition=full","pubTime":"2024-08-06 09:50","pubTimestamp":1722909043,"startTime":"0","endTime":"0","summary":"08月06日,高压氧舱概念盘中拉升,截至09点50分,高压氧舱概念整体指数上涨1.02%,报929.570点。从个股上来看,该概念的成分股中,盈康生命涨2.13%,国际医学、大湖股份、康德莱涨幅居前。从资金上来看,截止发稿,高压氧舱概念主力净流入为-32.77万,其中大湖股份受到资金热捧,主力净流入85.12万;拉长时间线来看,该板块近20日主力资金净流入-2.18亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806095043aefd6791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806095043aefd6791&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0236","300143","BK0213","600257","BK0188"],"gpt_icon":0},{"id":"2455637594","title":"7月29日盈康生命发布公告,其股东增持563.34万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455637594","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455637594?lang=zh_cn&edition=full","pubTime":"2024-07-29 18:01","pubTimestamp":1722247263,"startTime":"0","endTime":"0","summary":"证券之星消息,7月29日盈康生命发布公告《盈康生命:关于控股股东增持公司股份计划时间过半的进展公告》,其股东青岛盈康医疗投资有限公司于2024年4月30日至2024年7月29日间合计增持563.34万股,占公司目前总股本的0.8772%,变动期间该股股价下跌12.41%,截止7月29日收盘报7.27元。股东增减持详情见下表:根据盈康生命2024年一季报公布的十大股东详情如下:以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072900027332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2455663611","title":"盈康生命(300143.SZ)控股股东盈康医投增持期过半 累计增持563.34万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455663611","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455663611?lang=zh_cn&edition=full","pubTime":"2024-07-29 16:55","pubTimestamp":1722243320,"startTime":"0","endTime":"0","summary":"智通财经APP讯,盈康生命(300143.SZ)公告,公司控股股东青岛盈康医疗投资有限公司(简称“盈康医投”)增持计划实施时间已过半。自增持计划公告之日至2024年7月29日,盈康医投已累计增持公司股份563.34万股,占公司当前总股本的0.89%,增持金额为4467.37万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1156823.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2455361676","title":"【盈康生命(300143.SZ)控股股东盈康医投增持期过半 累计增持563.34万股】智通财经APP讯,盈康生命(300143.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455361676","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455361676?lang=zh_cn&edition=full","pubTime":"2024-07-29 16:55","pubTimestamp":1722243320,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["300143","BK0236","159891"],"gpt_icon":0},{"id":"2454864882","title":"盈康生命(300143)7月24日主力资金净卖出448.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454864882","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454864882?lang=zh_cn&edition=full","pubTime":"2024-07-25 09:21","pubTimestamp":1721870468,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月24日收盘,盈康生命报收于7.29元,下跌4.33%,换手率0.89%,成交量5.71万手,成交额4220.96万元。7月24日的资金流向数据方面,主力资金净流出448.02万元,占总成交额10.61%,游资资金净流入548.51万元,占总成交额12.99%,散户资金净流出100.49万元,占总成交额2.38%。近5日资金流向一览见下表:盈康生命融资融券信息显示,融资方面,当日融资买入475.98万元,融资偿还248.47万元,融资净买入227.52万元。盈康生命主营业务:医疗服务和医疗器械。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500014756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2453080640","title":"盈康生命:目前,公司自有医院中四川友谊医院和苏州广慈肿瘤医院已实施DRG支付政策","url":"https://stock-news.laohu8.com/highlight/detail?id=2453080640","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453080640?lang=zh_cn&edition=full","pubTime":"2024-07-23 19:01","pubTimestamp":1721732470,"startTime":"0","endTime":"0","summary":"目前,公司自有医院中四川友谊医院和苏州广慈肿瘤医院已实施DRG支付政策。公司已搭建完成以病种为切入的标准成本核算体系,将医保DRG系统和卫健委系统接轨,通过DRG结余、临床路径优化及绩效方案优化实现精细化运营。同时,公司持续加强学科、技术和人才建设,进一步提升临床入组率和CMI值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072300036042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2453775582","title":"盈康生命荣获证券之星ESG新标杆奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2453775582","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453775582?lang=zh_cn&edition=full","pubTime":"2024-07-23 11:25","pubTimestamp":1721705142,"startTime":"0","endTime":"0","summary":"为表彰经济效能与社会责任并重的绿色企业,为中国ESG发展提供示范性样本,助力上市公司引领绿色发展,履行社会责任,提升公司治理水平,助推经济可持续、高质量发展,本届ESG研讨会证券之星联合华证指数发布了2024年《ESG投资价值TOP100榜单》,并颁发证券之星ESG新标杆企业奖。盈康生命荣获证券之星ESG新标杆企业奖。2023年度,盈康生命积极履行其环境、社会和治理责任,通过一系列具体实践推动公司的可持续发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024072300017940.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143","161027","159717"],"gpt_icon":0},{"id":"2453759243","title":"盈康生命:截至2024年7月19日,公司股东总数为16,124户","url":"https://stock-news.laohu8.com/highlight/detail?id=2453759243","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453759243?lang=zh_cn&edition=full","pubTime":"2024-07-22 17:03","pubTimestamp":1721639007,"startTime":"0","endTime":"0","summary":"证券之星消息,盈康生命07月22日在投资者关系平台上答复投资者关心的问题。投资者:请问截至7月19日收盘,公司股东人数多少?截至2024年7月19日,公司股东总数为16,124户。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200022879.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2452975141","title":"盈康生命(300143)7月16日主力资金净卖出3.07万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452975141","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452975141?lang=zh_cn&edition=full","pubTime":"2024-07-17 09:21","pubTimestamp":1721179303,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月16日收盘,盈康生命报收于7.42元,下跌1.85%,换手率0.57%,成交量3.63万手,成交额2705.31万元。7月16日的资金流向数据方面,主力资金净流出3.07万元,占总成交额0.11%,游资资金净流入236.53万元,占总成交额8.74%,散户资金净流出233.46万元,占总成交额8.63%。融券方面,融券卖出2900.0股,融券偿还18.32万股,融券余量32.51万股,融券余额241.22万元。盈康生命主营业务:医疗服务和医疗器械。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700015274.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2450306236","title":"盈康生命(300143)7月10日股东户数1.65万户,较上期减少0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450306236","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450306236?lang=zh_cn&edition=full","pubTime":"2024-07-12 17:01","pubTimestamp":1720774877,"startTime":"0","endTime":"0","summary":"证券之星消息,近日盈康生命披露,截至2024年7月10日公司股东户数为1.65万户,较6月7日减少103.0户,减幅为0.62%。在医疗服务行业个股中,盈康生命股东户数低于行业平均水平,截至7月10日,医疗服务行业平均股东户数为4.1万户。从股价来看,2024年6月7日至2024年7月10日,盈康生命区间涨幅为3.55%,在此期间股东户数减少103.0户,减幅为0.62%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071200034580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","BK0236"],"gpt_icon":0},{"id":"2450886451","title":"盈康生命(300143)7月9日主力资金净买入68.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450886451","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450886451?lang=zh_cn&edition=full","pubTime":"2024-07-10 09:22","pubTimestamp":1720574577,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月9日收盘,盈康生命报收于7.51元,下跌0.92%,换手率1.01%,成交量6.49万手,成交额4862.36万元。7月9日的资金流向数据方面,主力资金净流入68.88万元,占总成交额1.42%,游资资金净流出38.67万元,占总成交额0.8%,散户资金净流出30.21万元,占总成交额0.62%。融券方面,融券卖出25.26万股,融券偿还3900.0股,融券余量49.07万股,融券余额368.52万元。盈康生命主营业务:医疗服务和医疗器械。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000015494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2450093927","title":"盈康生命旗下医院获“第四届创新医疗案例大赛”二等奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2450093927","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450093927?lang=zh_cn&edition=full","pubTime":"2024-07-09 15:12","pubTimestamp":1720509120,"startTime":"0","endTime":"0","summary":"2024年7月5日至6日,由艾力彼医院管理研究中心主办的“2024中国医院创新力大会暨第四届创新医疗案例大赛”在广州召开。本次案例大赛以“标杆引领 创新驱动新质生产力”为主题,汇聚全国272家医院提交的616项案例,其中,盈康生命旗下四川友谊医院的创新案例《信息化助力无呕规范化病房的建立》在大赛中脱颖而出,斩获本届创新医疗案例大赛·社会办医医院赛场二等奖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/enterprise/cn/2024-07-09/doc-inccppef8726257.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/cn/2024-07-09/doc-inccppef8726257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300143","BK0236","BK0096","002173","BK0114","BK0077"],"gpt_icon":0},{"id":"2448810549","title":"盈康生命:7月3日接受机构调研,华宝基金、国盛证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2448810549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448810549?lang=zh_cn&edition=full","pubTime":"2024-07-03 19:12","pubTimestamp":1720005154,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年7月3日盈康生命发布公告称公司于2024年7月3日接受机构调研,华宝基金易镜明 魏扬帆、国盛证券徐雨涵、安信基金方瑾、鹏扬基金王雪刚、银河基金方伟 毛泓洋、信泰人寿钱正茂、摩根基金钱正昊、上海开思私募陈镛方、兴业证券孙媛媛 王佳慧、华安证券陈珈蔚参与。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070300039100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","161027","300143"],"gpt_icon":0},{"id":"2448966396","title":"中邮证券:给予盈康生命买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2448966396","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448966396?lang=zh_cn&edition=full","pubTime":"2024-07-01 16:45","pubTimestamp":1719823519,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司蔡明子,龙永茂近期对盈康生命进行研究并发布了研究报告《定增获深交所通过,持续深化高质量发展》,本报告对盈康生命给出买入评级,当前股价为7.98元。本次向特定对象发行募集资金总额不超过9.7亿元,全部由盈康医投认购。最新盈利预测明细如下:该股最近90天内共有5家机构给出评级,买入评级5家;过去90天内机构目标均价为10.12。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070100021625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","161027"],"gpt_icon":0},{"id":"2448896397","title":"盈康生命涨5.98%,华安证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2448896397","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448896397?lang=zh_cn&edition=full","pubTime":"2024-07-01 16:13","pubTimestamp":1719821637,"startTime":"0","endTime":"0","summary":"今日盈康生命涨5.98%,收盘报7.98元。2024年4月23日,华安证券研究员谭国超,陈珈蔚发布了对盈康生命的研报《业绩符合预期,业务发展进入高质量新周期》,该研报对盈康生命给出“买入”评级。研报中预计公司2024~2026年将实现营业收入17.65/20.48/24.29亿元,同比+20.0%/16.0%/18.6%;实现归母净利润126/154/197百万元,同比+25.2%/22.1%/28.5%,对应PE40/32/25x,维持“买入”评级。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为华安证券的陈珈蔚。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070100020186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300143","600909"],"gpt_icon":0},{"id":"2447476605","title":"盈康生命9.7亿元定增获审核通过 彰显发展信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2447476605","media":"证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2447476605?lang=zh_cn&edition=full","pubTime":"2024-06-30 21:47","pubTimestamp":1719755220,"startTime":"0","endTime":"0","summary":"6月28日,深交所网站显示,盈康生命向特定对象发行证券的项目状态更新为“审核通过”。这意味着盈康生命的定增项目有了突破性进展。截至2024年3月31日,盈康医投直接持有公司39.93%股份。这对于盈康生命现有的其他投资者来说,无疑是一颗定心丸。盈康生命2023年年报显示,公司全年实现营业收入14.7亿元,同比增长27.20%,为2019年以来最高增速,实现归属于上市公司股东的净利润1亿元,同比增长116.85%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-06-30/doc-incaptyz2294657.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-06-30/doc-incaptyz2294657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0236","300143"],"gpt_icon":0},{"id":"2447703996","title":"盈康生命定增获深交所审核通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2447703996","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2447703996?lang=zh_cn&edition=full","pubTime":"2024-06-30 19:45","pubTimestamp":1719747900,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n北京商报讯(记者 丁宁)6月30日晚间,盈康生命(300143)发布公告称,公司于6月28日收到深交所上市审核中心出具的《关于盈康生命科技股份有限公司申请向特定对象发行股票的审核中心意见告知函》。深交所发行上市审核机构对公司向特定对象发行股票的申请文件进行了审核,认为公司符合发行条件、上市条件和信息披露要求,后续深交所将按规定报中国证监会履行相关注册程序。据了解,盈康生命本次发行的股份,将全部由公司控股股东青岛盈康医疗投资有限公司认购,募集资金总额为9.7亿元,认购价格为8.99元/股。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-06-30/doc-incapptf9322371.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-06-30/doc-incapptf9322371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0236","300143"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2010-12-09","address":"山东省青岛市城阳区春阳路37号","stockEarnings":[{"period":"1week","weight":-0.048},{"period":"1month","weight":-0.0206},{"period":"3month","weight":-0.0881},{"period":"6month","weight":-0.1678},{"period":"1year","weight":-0.2647},{"period":"ytd","weight":-0.3283}],"companyName":"盈康生命科技股份有限公司","boardCode":"AI0083","perCapita":"39851股","boardName":"卫生","registeredCapital":"64216万元","compareEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":-0.0164},{"period":"3month","weight":-0.0759},{"period":"6month","weight":-0.0501},{"period":"1year","weight":-0.0739},{"period":"ytd","weight":-0.0405}],"survey":" 盈康生命科技股份有限公司主营业务为以肿瘤为特色的医疗服务以及关键场景、关键设备医疗器械的研发、创新和服务。公司主要产品和服务有伽玛刀及医疗服务。公司在医疗器械方面:国内头部伽玛刀领域龙头企业,并率先实现大型放疗设备自主出口,成功打破国际大型公司全球垄断地位。","serverTime":1724534189420,"listedPrice":36,"stockholders":"16114人(较上一季度减少0.06%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盈康生命(300143)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盈康生命(300143)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盈康生命,300143,盈康生命股票,盈康生命股票老虎,盈康生命股票老虎国际,盈康生命行情,盈康生命股票行情,盈康生命股价,盈康生命股市,盈康生命股票价格,盈康生命股票交易,盈康生命股票购买,盈康生命股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盈康生命(300143)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盈康生命(300143)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}